RIVER NEWS TUESDAY 7.17.18
Belmont County GOP Chairman Announces Resignation
Belmont County Republican Party Chairman Chris Gagin has announced his resignation.
He made the announcement concerning his chairman position Monday evening on Twitter in a series of tweets, citing his duty and policy differences. He also cited the earlier summit between President Donald Trump and Russian President Vladimir Putin in his explanation.
“The President is entitled to GOP party leaders, at all levels, fully committed to his views and agenda. Following today’s press conference with Pres. Putin, as well as certain policy differences, most especially on trade, I could no longer fulfill that duty. Thus, I resigned.”
Wheeling Police Arrest Two for Drugs
Two separate traffic stops turn into two drug arrests in Wheeling.
Both happened on Wheeling Island in back-to-back days.
Sponsored by ZINC
The first came on Sunday around 5 in the evening on S. Penn Street.
John Wesley Blair is charged with possession of crack cocaine.
The second happened around 3 a.m. on Monday on Zane Street.
Police say a burnt-out taillight led to the arrest of Michael Forrest, who was charged with possession with intent to deliver narcotics.
Both men are in the Northern Regional Jail.
OSU Diving Coach Accused of Sexual Assault
A Lawsuit accuses former OSU diving coach Will Bohonyi of sexually assaulting underage athletes…
Ohio News Network’s Glenn McIntyre…according to the lawsuit, a teammate of the victim told OSU’s diving coach about the sexual abuse in August of 2014, but OSU performed an internal investigation instead of reporting the assault to the police.
Power Restored to Elm Grove
Power was restored for people living in the Elm Grove area of Wheeling around 8 p.m., Monday.
It had been out since Monday morning after a fallen tree hit some power lines and caused a pole to split.
Many residents went more than 12 hours without power in their homes on one of the hottest days of the year so far.
FDA Announces Recall of Blood Pressure Medicine due to Possible Cancer Risk
The U.S. Food and Drug Administration has announced a recall of several drug products that are used to treat high blood pressure, due to a potential cancer risk.
According to the FDA, several drug products containing the active ingredient valsartan, which is used to treat high blood pressure and heart failure, are being voluntarily recalled due to the possible impurity of a potential carcinogen N-nitrosodimethylamine (NDMA).
The FDA says that patients who are taking the recalled valsartan-containing medicines should continue taking their medicine until they have a replacement product.
To determine whether a specific product has been recalled, patients should look at the drug name and company name on the label of their prescription bottle. If the information is not on the bottle, patients should contact the pharmacy that dispensed the medicine.
Patients should also contact their health care professional (the pharmacist who dispensed the medication or doctor who prescribed the medication) if their medicine is included in this recall to discuss their treatment, which may include another valsartan product not affected by this recall or an alternative treatment option.
The following drugs have been recalled:
Valsartan Major Pharmaceuticals
Valsartan Solco Healthcare
Valsartan Teva Pharmaceuticals Industries Ltd.
Valsartan/Hydrochlorothiazide (HCTZ) Solco Healthcare
Valsartan/Hydrochlorothiazide (HCTZ) Teva Pharmaceuticals Industries Ltd.